Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Atherosclerosis|June 15, 2018
Ticagrelor, a P2Y12 antagonist, attenuates vascular dysfunction and inhibits atherogenesis in apolipoprotein-E-deficient miceByambasuren Ganbaatar, Daiju Fukuda, Hotimah Masdan Salim, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|November 24, 2004
Temporal and spatial characterization of cellular constituents during neointimal hyperplasia after vascular injury: Potential contribution of bone-marrow-derived progenitors to arterial remodelingMakoto Shoji, Masataka Sata, Daiju Fukuda, et al.
Circulation|November 28, 2022
NLRP3 Inflammasome Activation Through Heart-Brain Interaction Initiates Cardiac Inflammation and Hypertrophy During Pressure OverloadYasutomi Higashikuni, Wenhao Liu, Genri Numata, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 26, 2011
The ATP-binding cassette transporter ABCG2 protects against pressure overload-induced cardiac hypertrophy and heart failure by promoting angiogenesis and antioxidant responseYasutomi Higashikuni, Julie Sainz, Kazuto Nakamura, et al.
Frontiers in Cardiovascular Medicine|November 22, 2018
Activation of Toll-Like Receptor 9 Impairs Blood Flow Recovery After Hind-Limb IschemiaSachiko Nishimoto, Kunduziayi Aini, Daiju Fukuda, et al.
Atherosclerosis|March 31, 2015
Rivaroxaban, a novel oral anticoagulant, attenuates atherosclerotic plaque progression and destabilization in ApoE-deficient miceTomoya Hara, Daiju Fukuda, Kimie Tanaka, et al.
Molecular Microbiology|December 23, 2004
Cell size and nucleoid organization of engineered Escherichia coli cells with a reduced genomeMasayuki Hashimoto, Toshiharu Ichimura, Hiroshi Mizoguchi, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 13, 2002
Mouse genetic evidence that tranilast reduces smooth muscle cell hyperplasia via a p21(WAF1)-dependent pathwayMasataka Sata, Akihiro Takahashi, Kimie Tanaka, et al.
Atherosclerosis|October 17, 2016
Combination of n-3 polyunsaturated fatty acids reduces atherogenesis in apolipoprotein E-deficient mice by inhibiting macrophage activationAkira Takashima, Daiju Fukuda, Kimie Tanaka, et al.
European Journal of Pharmacology|December 11, 2012
Exendin-4, a glucagon-like peptide-1 receptor agonist, attenuates neointimal hyperplasia after vascular injuryYoichiro Hirata, Hirotsugu Kurobe, Chika Nishio, et al.
Pageof 5